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Abstract
Crypts are the basic structural and functional units of colonic epithelium and can be isolated from 
the colon and cultured in vitro into multi-cell spheroids termed “colonoids”. Both crypts and 
colonoids are ideal building blocks for construction of an in vitro tissue model of the colon. Here 
we proposed and tested a microengineered platform for capture and in vitro 3D culture of colonic 
crypts and colonoids. An integrated platform was fabricated from polydimethylsiloxane which 
contained two fluidic layers separated by an array of cylindrical microwells (150-μm diameter, 
150-μm depth) with perforated bottoms (30-μm opening, 10-μm depth) termed “microstrainers”. 
As fluid moved through the array, crypts or colonoids were retained in the microstrainers with a 
>90% array-filling efficiency. Matrigel as an extracellular matrix was then applied to the 
microstrainers to generate isolated Matrigel pockets encapsulating the crypts or colonoids. After 
supplying the essential growth factors, epidermal growth factor, Wnt-3A, R-spondin 2 and noggin, 
63±13% of the crypts and 77±8% of the colonoids cultured in the microstrainers over a 48–72 h 
period formed viable 3D colonoids. Thus colonoid growth on the array was similar to that under 
standard culture conditions (78±5%). Additionally the colonoids displayed the same morphology 
and similar numbers of stem and progenitor cells as those under standard culture conditions. 
Immunofluorescence staining confirmed that the differentiated cell-types of the colon, goblet cells, 
enteroendocrine cells and absorptive enterocytes, formed on the array. To demonstrating the utility 
of the array in tracking the colonoid fate, quantitative fluorescence analysis was performed on the 
arrayed colonoids exposed to reagents such as Wnt-3A and the γ-secretase inhibitor LY-411575. 
The successful formation of viable, multi-cell type colonic tissue on the microengineered platform 
represents a first step in the building of a “colon-on-a-chip” with the goal of producing the 
physiologic structure and organ-level function of the colon for controlled experiments.
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Microengineered devices are unique tools for the culture and interrogation of cells and 
tissues in vitro by virtue of their ability to control the cellular microenvironment both 
temporally and spatially.1 Microdevices specifically designed to mimic in vivo organ 
microarchitecture and function, called “organ-on-chips”, are envisioned to expand the 
capabilities of cell culture models and provide better controlled experimental alternatives to 
animal studies.2–4 An excellent example of organ-on-chips is a physiologically functional 
“lung-on-a-chip” that reconstitutes the dynamic mechanical strain and alveolar-capillary 
interface of the human lung.5 Various other organ-on-chips have been reported including 
liver,6 heart,7 blood vessel,8 muscle,9 kidney,10 and gastrointestinal tract,11–13 by 
recapitulating a specific feature of the organ microenvironment (e.g. topography, tissue-
tissue interface, mechanical movement, shear stress, biochemical gradient).
While these organ-on-chips have created novel in vitro models that permit the study of some 
aspects of human physiology, many of them still rely on the use of immortalized cell lines 
derived from tumors. For example, Caco-2 cells derived from a colon carcinoma were used 
in several “gut-on-chips” to mimic the intestinal epithelium.11–13 Although these tumor cell 
lines can form a contiguous monolayer, their cancer phenotype poorly reflects normal tissue 
physiology or microarchitecture found in vivo. This issue points to one of the major 
challenges of organ-on-chips which is the use of primary cells derived from normal tissue to 
form systems more representative of in vivo organ systems.3
The subunit of the living colon is the crypt which is a micron-scale tubular structure 
comprised of a single layer of columnar epithelium that invaginates into the underlying 
connective tissue of the lamina propria. The colonic epithelium is the most rapidly renewing 
tissue in the mammalian body with a renewal time of 3–5 days for mice.14 This tissue 
regeneration is driven by a pool of multipotent colonic epithelial stem cells at the base of the 
crypts.15 The stem cells give rise to transient amplifying progenitor cells that terminally 
differentiate into three major types of epithelial cells as they migrate from the base of the 
crypt towards the lumen: goblet cells (secreting mucus), absorptive colonocytes (absorbing 
water and electrolytes), and enteroendocrine (secreting hormones). The self-renewal 
property of crypts provides homeostasis to the colonic epithelium, while the different cell 
types enable a range of functions to be accomplished by the colon. Therefore, crypts are 
ideal building units for constructing an in vitro tissue model within a microdevice.
A previous effort to design a microdevice for capture and biological assay of colonic crypts 
used polymer crypt-surrogates and fixed crypts.16 A freestanding film microfabricated from 
epoxy photoresist containing an array of micron-scale capture sites, termed a micromesh 
(open holes), was used to capture fixed crypts with high efficiency in an ordered and 
properly oriented fashion.16 However, this micromesh structure was less effective at 
capturing and retaining live crypts likely because crypts are much softer and more 
deformable than crypt surrogates and fixed crypts. For example, when live crypts 
approached the holes via fluidic flow, they deformed and did not properly enter the holes. 
Additionally, the structures were readily dislodged when reagents were added to the device 
and the crypts were viable for only a few hours.
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In vitro culture of live crypts and intestinal stem cells has been attempted for decades with 
little success until the pioneering work by the Clevers and colleagues in 2009 in which long-
term culture of crypts and stem cells from the small and large intestines was achieved by 
virtue of the identification of a number of critical factors needed for cell maintenance and 
proliferation.17–21 One of the most substantial difficulties overcome was the blockage of 
rapid apoptosis following removal of crypts from the basement membrane by addition of a 
ROCK inhibitor to the initial culture media. A second accomplishment was identification of 
growth factors (Wnt-3A, R-spondin 1, noggin and epidermal growth factor [EGF]) that were 
required for support of the colonic epithelium. These factors enable long term survival of 
colonic epithelial cells when added exogenously to a 3D extracellular matrix (ECM). This 
3D culture system supports the growth of colonoids (defined as colonic organoids without 
mesenchyme),22 which contain self-renewing stem cells as well as all of the differentiated 
cell types present in crypts. The development of this culture technology provides the 
opportunity to design microdevices to support a living colonic epithelium for in vitro studies 
in a user-controlled microenvironment.
The goal of the current work was to create a viable colonoids microarray with potential for a 
variety of uses including the study of colonic cell physiology and the stem-cell proliferation 
and differentiation. Microfabrication was combined with primary colonic tissue culture to 
create a viable colonoid microarray. A microengineered crypt-like architecture was 
developed on the arrays using biocompatible substrates. Crypts and colonoids captured on 
the array were embedded in Matrigel to form an array of extracellular matrix plugs encasing 
the living cells. Crypt survival and growth were quantitatively assessed in culture conditions 
that mimicked the native colonic crypt niche with provision of the essential growth factors 
of EGF, Wnt-3A, R-spondin and noggin. Finally, to explore the feasibility of using the 
device as an in vitro drug screening platform, the arrayed colonoids were subjected to small 
molecule inhibition of the Notch pathway, LY-411575.
Experimental Section
Materials
Fluorescein isothiocyanate–dextran (FITC-dextran, average molecular weight 2,000,000), 
Y-27632 dihydrochloride (ROCK inhibitor), N-acetyl-L-cysteine (NAC), and LY-411575 
(γ-secretase inhibitor) were purchased from Sigma Aldrich. The 1002F epoxy photoresist 
was formulated according to a previous publication.23 Polydimethylsiloxane (PDMS) was 
prepared from the Sylgard 184 silicone elastomer kit (Dow Corning). Advanced DMEM/
F-12 medium, EGF recombinant mouse protein, N-2 supplement, B-27 supplement, 
GlutaMAX supplement, penicillin-streptomycin, fetal bovine serum (FBS), HEPES (1M 
buffer solution), and G418 sulfate were obtained from Invitrogen. Mouse noggin 
recombinant protein was from eBioscience. Growth factor reduced Matrigel and collagen 
(type I from rat tail) were purchased from BD. Collagenase (type 4) was purchased from 
Worthington Biochemical. All other reagents including dithiothreitol (DTT), bovine serum 
albumin (BSA) and ethylenediaminetetraacetic acid (EDTA) were from Fisher Scientific.
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Isolation of crypts from colons
Crypts were isolated from wild type and CAG-DsRed/Sox9-EGFP mice (6–9 week old) 
using previously described methods.24 The CAG-DsRed/Sox9-EGFP mouse used in this 
study is a cross between a bacterial-artificial-chromosome-transgenic mouse in which the 
enhanced green fluorescent protein (EGFP) is expressed as a function of the Sox9 regulatory 
region (Sox9-EGFP mouse),25, 26 and the CAG-DsRed mouse (CAG = CMV enhancer plus 
chicken actin promoter) that harbors a transgene for the DsRed protein.17, 26, 27 All 
experiments were performed in compliance with the relevant laws and institutional 
guidelines at the University of North Carolina. All experiments and animal usage was 
approved by the Institutional Animal Care and Use Committee at UNC.
Off-chip 3D culture of colon crypts
Isolated crypts were embedded in collagen for in vitro 3D culture according to previous 
publications with minor modification.21, 24 Briefly, isolated crypts were counted using a 
hemocytometer. A total of 5,000 crypts were suspended in 500 μL of type 1 rat tail collagen 
at 2 mg/ml and placed in a 12-well plate. After polymerization of the collagen at 37 °C for 
30 min, 2 mL of crypt culture medium (CCM) was added to the well. CCM was prepared 
from a mixture of advanced DMEM/F12 medium, Wnt-3A-conditioned medium, and R-
spondin 2-conditioned medium at a volumetric ratio of 2:1:1, and supplemented with noggin 
(100 ng/mL), EGF (50 ng/mL), N2 (1×), B27 (1×), Y27632 ROCK inhibitor (10 μM), NAC 
(1 mM), GlutaMAX (1×), HEPES (10 mM), penicillin (100 unit/mL), and streptomycin (100 
μg/mL). The detailed steps to prepare Wnt3A and R-Spondin 2-conditioned media are 
described in the supplementary information. CCM was prepared in a bulk volume of 500 mL 
and split into 6-mL aliquots and stored at −80 °C until use. The medium was changed every 
48 h. The crypts grew into colonoids in culture (Fig. 1). To harvest the colonoids, the 
collagen gel was digested in DMEM containing collagenase type 4 (500 U/mL) at 37 °C for 
15 min. The released colonoids were washed with PBS containing 0.5% BSA, centrifuged at 
300 g for 2.5 min, and suspended in DMEM for immediate use.
Fabrication of a freestanding PDMS microstrainer array
A freestanding PDMS membrane containing an array of microstrainers was prepared by 
three microfabrication steps (Fig. S1), the details of which are described in the 
supplementary information. In the first step, a master mold composed of an array of 
microstrainers firmly adhered to the glass substrate was fabricated from 1002F photoresist 
by a two-layer photolithography process (Fig. S1A).16 A 10-μm thick 1002F film was 
fabricated first on the glass as the base. The structure was composed of a 10-μm thick grid 
within 30-μm square or circular openings. Then a 150-μm thick 1002F film was coated on 
the top of the base, and holes of 150 μm in diameter were fabricated in the top layer. In the 
second step, a PDMS mold was prepared by replicate molding of PDMS on the master mold 
(Fig. S1B). The PDMS mold contained an array of large posts (150 μm in height, 150 μm in 
diameter) with small posts (10 μm in height, 30 μm in diameter or length) at the top of each 
large post. In the third step, a PDMS microstrainer array was fabricated by replicate molding 
under pressure (Fig. S1C). The PDMS microstrainer had the same geometry as the epoxy 
microstrainer on the master mold.
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Integration of the microstrainer array into a device
Soft lithography was used to fabricate two fluidic layers (a top layer and a bottom layer) that 
were integrated above and below a microstrainer array to create a 2-channel microfluidic 
platform in PDMS (Fig. 2D). The array and the top layer were plasma treated for 2 min, 
aligned and brought into conformal contact to form permanent bonding. Then the bottom 
layer was bonded to the other side of the array in the same manner. The assembled device 
was then baked at 95 °C overnight to enhance the bond strength.
Capture of crypts, selective placement of Matrigel, and on-chip culture of crypts on the 
microstrainer array
The device was sterilized with 70% ethanol and rinsed with PBS buffer ×5. Trapped air 
bubbles inside the microstrainers were removed by degasing the device in a covered Petri 
dish. The microstrainer array was treated with 1% BSA for 1 h at room temperature, and 
rinsed with PBS buffer ×3 prior to loading crypts. To load crypts on the array, a suspension 
of crypts in DMEM was added to port 1 and 2 followed by addition of PBS buffer. Gravity 
drove a trans-array flow delivering the crypts to the wells in the microstrainer array. The 
ratio of crypts:wells was 2:1. Once the crypts were captured on the array, buffer was 
aspirated from the channels, which was then quickly filled with cold liquid Matrigel (50% 
dilution in CCM, 4 °C), and incubated at room temperature for 5 min. Aspiration of liquid 
Matrigel from the channels generated isolated Matrigel pockets embedding the crypts. After 
this step, the device was placed at 37 °C for 10 min to solidify the Matrigel. CCM (1 mL) 
was then added to the top and bottom fluidic layers for crypt culture. Medium was changed 
every 24 h. Colonoids were loaded and cultured on the device in the same manner as the 
isolated crypts.
Microscopy
The crypts and colonoids were imaged using a Nikon Eclipse TE300 inverted 
epifluorescence microscope equipped with DAPI/FITC/Texas Red filter sets. Wide-field 
imaging of the entire array was obtained using an Olympus MVX-10 research macro zoom 
fluorescence microscope equipped with FITC/Texas Red filter sets. 3D images of crypts 
embedded in solidified Matrigel pockets (mixed with 100 μg/mL FITC-dextran) on the array 
were obtained using an Olympus spinning disk confocal microscope equipped with FITC/
Texas Red filter sets. The PDMS microstrainer array was inspected by SEM (FEI Quanta 
200 ESEM, FEI Company).
Immunofluorescence
Crypts isolated from a wild-type mouse were used for immunofluorescence (IF). The freshly 
isolated crypts and in vitro cultured colonoids on the array were fixed with 4% 
paraformaldehyde for 20 min, followed by permeabilization with 0.5% Triton X-100 for 20 
min. IF staining was performed using the following primary antibodies: rabbit anti-Muc2 
(1:200, Santa Cruz, #SC-15334), rabbit anti-chromogranin A (1:1000, Bioss, #bs-0539R), 
mouse anti-carbonic anhydrase II (1:500, Santa Cruz, #SC-48351). The secondary 
antibodies were donkey anti-rabbit or mouse antibodies conjugated with NL594 and NL637 
(1:200, Santa Cruz). DNA was stained with Hoechst 33342 (1 μg/mL, Sigma Aldrich, 
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#B2261). The stained crypts and colonoids were imaged using the Nikon Eclipse TE300 
microscope described above.
Time-lapse imaging of colonoids in response to the growth factor, Wnt-3A
To study the effect of Wnt-3A, crypts isolated from a CAG-DsRed/Sox9-EGFP mouse were 
captured and cultured on two arrays. One array was cultured in the absence of Wnt-3A, 
while the other one was cultured in CCM and served as the control. Images were collected 
with a cooled CCD camera (Photometrix Cool Snap HQ2; Roper Scientific, Tucson, AZ) 
using a Micro-Manager hardware control interface.28 Image analysis was performed using a 
custom script implemented in MATLAB (MathWorks; Natick, MA). Briefly, centers of the 
wells in the array were detected using an implementation of the Hough transform for 
detecting circles.29 Detected wells in overlapping the image edge were rejected from 
analysis and the remaining well centers were used to generate a segmentation mask for each 
field-of-view within the array. This mask was then used to integrate fluorescence intensities 
for each colonoid on the acquired images. For experiments in which dynamic properties 
were tracked, the first image in the sequence was selected for segmentation and the resulting 
mask applied to all images in the sequence.
Gamma-secretase inhibition
To study the effect of a γ-secretase inhibitor, crypts isolated from a CAG-DsRed/Sox9-
EGFP mouse were captured on the two chips and encapsulated with Matrigel. One chip was 
cultured in CCM containing 1 μM LY-411575,30 while the other one without LY-411575 
served as the control. The medium was changed every 24 h. At 48 h, the colonoids on the 
arrays were fixed and stained with Hoechst 33342. The arrays were imaged on an Olympus 
MVX-10 microscope to quantify Sox9 (EGFP) expression as well as DNA content (Hoechst 
33342). Image analysis was performed using a custom script implemented in MATLAB 
based on user initialization of the capture array geometry. The fluorescence intensity was 
analyzed by two-sample student’s t-test. Statistical significance for comparisons was 
assigned at P < 0.05.
Results and Discussion
Use of a CAG-DsRed/Sox9-EGFP mouse model to facilitate quantification of colonoid 
growth and differentiation
Transgenic mouse models expressing multiple fluorescent proteins have enabled 
identification and tracking of cells within viable crypts.17, 26, 27 A CAG-DsRed/Sox9-EGFP 
mouse model was used in which DsRed was constitutively expressed while EGFP was 
expressed in intestinal epithelial stem and progenitor cells, but not in the differentiated 
colonic epithelium.25 This model allows monitoring and quantification of undifferentiated 
cells (Sox9EGFP+; red and green) and differentiated cells (red only) by fluorescence 
microscopy (top scheme in Fig. 1A).
Two types of colonic epithelial samples were prepared for experiments, freshly isolated 
crypts or colonoids cultured from previously isolated crypts. Production of colonoids 
enabled expansion of the primary cells and minimized the numbers of animals required for 
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tissue procurement. To produce this expanded tissue sample, isolated crypts were embedded 
in a patty of collagen hydrogel and supplied with essential growth factors (EGF, Wnt-3A, R-
spondin 2 and noggin) and an apoptosis inhibitor (Y27632).17, 21, 24 Of the isolated crypts, 
78±5% (a total number of 60 crypts counted in 3 culture experiments) formed colonoids 
when cultured for 3 days (Fig. 1B). When cultured under these conditions, the cells in the 
luminal portion of the crypts rapidly died while the crypt base containing the stem cells 
persisted in culture and developed into colloid structures. Colonoids continued to grow and 
by day 3 possessed an enclosed central lumen (Fig. 1). Thus, the crypts underwent a 
dramatic change in morphology during in vitro culture from open and elongated (at day 0) to 
enclosed and spherical (at day 3). Freshly isolated crypts possessed a diameter at the luminal 
end of 100 ± 23 μm, a basal diameter of 50 ± 10 μm and a length of 241 ± 49 μm (n=20). By 
day 3, the spherical colonoids cultured displayed a diameter of 110 ± 43 μm (n=20). In 
addition to the change in shape, compartmentalization of the various cell types was lost 
during in vitro culture. Colonoids possessed a non-polarized structure with self-renewing 
stem/progenitor cells (EGFP) and differentiated epithelial cell types (DsRed) being 
randomly dispersed (Fig. 1B). These cultured colonoids could be harvested from the 
collagen gel by digestion with collagenase which also fragmented the larger structures to 
yield increased numbers of smaller colonoids. The tissue could then be utilized for assays or 
further expanded in culture.
The freshly isolated crypts and in vitro cultured colonoids demonstrated distinct advantages 
and disadvantages. Freshly isolated crypts resembled the in vivo state of the colonic 
epithelium in terms of morphology, cell segregation and tissue polarization, but their 
elongated shape made it difficult to control their orientation on microdevices. Colonoids 
were readily manipulated in microdevices due to their spherical morphology, but their shape 
and lack of a distinct stem-cell and differentiated-cell compartments did not mimic that of in 
vivo crypts. In this study, both freshly isolated crypts and in vitro cultured colonoids (48 h in 
off-chip culture) were prepared in suspension and used as a tissue sources for the 
microdevices.
Fabrication of the microstrainer array and its integration into a device
Currently, the standard approach to in vitro culture of crypts uses conventional culture 
devices such as multi-well plates and Transwell permeable inserts.24, 26, 31 A 
microengineered device to efficiently array and maintain living crypt tissue would represent 
a highly efficient and cost effective platform and provide unprecedented user-controlled 
fluidic microenvironments. To achieve such a tool, a freestanding film containing a 
microstructure termed a microstrainer array was fabricated to capture and retain live crypts. 
The microstrainer array was composed of deep, cylindrical microwells (150-μm diameter, 
150-μm depth) with a thin, grid-like bottom layer (30-μm opening, 10-μm depth) (Fig. 2A–
C). The gridded bottom layer was designed to permit fluid to flow through the microwells 
while blocking crypt passage. The depth of the microwells was expected to enable crypt 
retention in the array sites during reagent manipulation. Arrays similar to that used here have 
been fabricated from epoxy photoresist by a two-layer photolithography process.16, 32 In this 
study, PDMS was selected as the material to fabricate the microstrainer array due to its low 
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autofluorescence, biocompatibility, wide acceptance in the microfluidic community, and 
ease in bonding with other fluidic layers to form integrated devices.
A process composed of three microfabrication steps was used to fabricate the PDMS 
microstrainer array with the details described in the supplementary information. During the 
final fabrication step (Fig. 2A), a soft lithography-based replica molding method was 
employed similar to that used for fabricating a PDMS porous membrane.11 PDMS pre-
polymer was sandwiched between a glass slide and a post-array mold under a uniform 
pressure generated by a 0.75 kg weight. Thermal cure and subsequent demolding yielded a 
high quality PDMS microstrainer array (Fig. 2B). The bottom layer was perforated with 
unobstructed holes (Fig. 2C). Each array was composed of 3×3 subgroups, and each 
subgroup contained 10×10 microstrainers, resulting in a total of 900 microstrainers per 
array. In order to track the growth of crypts, each microstrainer was provided an address 
designated by a combination of letters and numbers. For example, the address of the 
microstrainer in the upper/right corner of Figure 2B is “AA-5a” where “AA” denotes the 
subgroup, “5” and “a” are x and y coordinates of the microstrainer in this subgroup.
To form an integrated microfluidic device, the microstrainer array was sandwiched and 
sealed by plasma-activated bonding of two PDMS layers (Fig. 2D–F). The top layer 
contained a central chamber (8 mm in diameter) and four through holes (8-mm in diameter) 
that provided access points for fluid flow through the device. The bottom layer possessed 
three cylindrical chambers. The integrated device contained two fluidic layers separated by 
an array of microstrainers that divided the central chamber into luminal and basal 
compartments. Ports 1 and 2 connected the luminal compartment, while ports 3 and 4 
connected the basal compartment (Fig. 2E). The fluidic flow in the platform was controlled 
by four ports: 1→2 for flow through the luminal compartment, 3→4 for flow through the 
basal compartment, and 1→4 or 2→3 for trans-array flow. Fig. 2F shows a photograph of 
the integrated platform.
Capture of crypts on the microstrainer array and selective placement of Matrigel
Crypts were loaded onto the array by pipette and moved through the channels by vacuum 
aspiration so that no pumps and valves were needed (Fig. 3A). A suspension of crypts was 
added to ports 1 and 2 followed by addition of PBS buffer to these reservoirs. At the same 
time PBS was removed from ports 3 and 4 driving a trans-array flow which transported the 
crypts to the microstrainer. As fluid moved through the porous base of the microstrainers the 
crypts were retained in the microstrainers (Fig. 3A-ii). This simple loading strategy yielded 
>90% capture efficiency (i.e. percentage of microstrainers on the array that was filled with 
crypts/colonoids) when a crypt:well ratio of 2:1 was employed (Fig. 3B,C). Since the crypts 
were on average 241 ± 49 μm in length, many crypts were deformed as they entered the 
microstrainer (diameter = 150 μm) (Fig. 3D). Some microstrainers captured more than one 
crypt which was deemed acceptable, since it was observed that two adjacent crypts within a 
microwell always fused into one colonoid during culture. Colonoids that were formed in 
culture prior to loading on the array were also captured on the microstrainer array with 
>90% capture efficiency (Fig. S2A) but without deformation due to their spherical shape 
and small size (Fig. 3E). If capture of single crypt per microstrainer is needed, e.g. in 
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conducting clonal analysis of crypts in vitro, a low crypt:well ratio (e.g. 0.2:1) can be 
employed (Fig. S2B).
Intestinal epithelial cells undergo rapid apoptosis termed anoikis when they are detached 
from basement membrane.33 To maintain the viability of crypts in the microstrainers, the 
crypts must be embedded in an ECM hydrogel as quickly as possible. Laminin is enriched in 
basement membranes surrounding the crypts and laminin-rich Matrigel has been shown to 
be effective in maintaining the viability of crypts and maintaining colonic stem cells.17 For 
this reason arrayed crypts were embedded in Matrigel pockets immediately after loading 
onto the array (Fig 3A). After crypts capture on the array (Fig. 3A-ii), buffer was aspirated 
from the channels which were then quickly filled with cold liquid Matrigel (Fig. 3A-iii). 
Liquid Matrigel was then aspirated from the channels leaving an isolated Matrigel plug in 
each microstrainer well. Incubation of the device at 37°C caused the Matrigel to gel and 
encase the crypts (Fig. 3A-iv). When the Matrigel was premixed with fluorescein-dextran, 
confocal, fluorescence microscopy confirmed that the crypts were embedded in isolated 
Matrigel pockets that had the same height and diameter as the microstrainers (Fig. 3F–H). 
Finally medium was added to the upper and lower compartments to supply the crypts with 
nutrients and growth factors (Fig. 3A-v). Although the diffusion of growth factors in 
Matrigel is slow, e.g. with a diffusion coefficient on the order of 106 μm2/hour for vascular 
endothelial growth factor (38.2 kDa),34 the micron-scale Matrigel pockets ensured the 
efficient delivery of growth factors to the crypts, and removal of metabolic wastes from the 
crypts. Addition and removal of medium demonstrated that the crypts or colonoids were 
held firmly in the Matrigel pockets as none were found to be dislodged from the array 
during medium exchange. After capture of crypts or colonoids, media was placed in the 
upper and lower compartments. After initial media placement, no fluid flow was present.
In vitro culture of crypts and colonoids in the microstrainer array
Within the microstrainers, crypts formed 3D colonoids over a 72-h period and the colonoids 
displayed a similar spherical morphology to present under standard growth conditions (Fig. 
4A). Many colonoids filled the entire lumen of the microstrainers by 72 h. Cell debris was 
present on the surface of the microstrainer and likely originated from the expected apoptosis 
of cells in the luminal portion of the crypts. The efficiency of crypt growth into colonoids 
was assessed by comparing the DsRed fluorescence image after 1 and 72 h in culture for 60 
wells in 3 independent culture experiments. Of the crypts loaded into the microstrainers, 
63±13% grew into colonoids, a number similar to that under standard off-chip culture 
conditions (78±5%). All of the living crypt/colonoids expressed EGFP fluorescence and thus 
possessed Sox9-expressing cells indicating that stem/progenitor cells were present in the 
colonoids. These data suggested that the material (PDMS) and geometric constraints 
(microstrainer) did not exert a substantially negative effect on the growth of isolated crypts 
into colonoids.
Colonoids cultured off-chip could also be captured and then cultured on the array (Fig. 4B) 
in a manner similar to that of the crypts. Sox9+ stem/progenitor cells were preserved in the 
colonoids during culture on the device as evidenced by the continued expression of EGFP 
(Fig 4B). Of the colonoids loaded onto the array, 77±8% (n=60 in 3 independent 
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experiments) continued to expand in size on the array at 48 h which was similar to the 
survival rate of crypts loaded onto the array. By 48 h, the living colonoids filled the entire 
lumen of the microstrainers (Fig. 4B). At 72 h, over 70% of the 900-capture sites were filled 
with viable, 3D colonoids possessing stem/progenitor cells as indicated by the presence of 
EGFP in 100% of the colonoids (Fig. 4C). These experiments demonstrate that either freshly 
isolated crypts or in vitro cultured colonoids could be used as the tissue source for the 
microstrainer array.
To assess whether the colonoids on the microstrainer array possessed the full repertoire of 
differentiated lineages, immunostaining for lineage-specific markers was conducted on 
arrayed colonoids derived from a wild type mouse. At 72 h, the colonoids were fixed and 
stained for Muc2 (goblet cells), chromogranin A (enteroendocrine cells), and carbonic 
anhydrase II (enterocytes).21 In freshly isolated crypts, stem/progenitor cells (Sox9+) are 
localized at the base of the crypts (Fig. 4D-i, left,). In contrast, stem/progenitor cells in 
colonoids were the predominant cell type and were randomly dispersed (Fig. 4D-i, right). 
The Wnt-3A protein in the culture medium favored the expansion of stem/progenitor cells 
since Wnt acts to support the undifferentiated progenitor cell type.19 Mature, differentiated 
goblet cells (Muc2+), which secrete mucus to protect and lubricate the colon, are found at 
the luminal portion of the crypts but were dispersed throughout the colonoids (Fig. 4D-ii). 
Enteroendocrine cells (CGA+), which release hormones or peptides to control important 
physiological functions of the colon, are present in in low numbers in freshly isolated crypts, 
and were also rarely observed in the colonoids (Fig. 4D-iii). Colonic enterocytes (CAII+), 
which uptake water and ions from the solid waste in the colon, are located along the luminal 
portion of the crypts. These cells were present in the colonoids but dispersed throughout the 
colonoid at random locations (Fig. 4D-iv). The differentiated cells wre found in the majority 
of imaged wells (Fig. S3). The immunofluorescence staining of colonoids on the array was 
independent on the source of tissue (fresh crypts or off-chip cultured colonoids) (Fig. S4). 
These findings are consistent with the numerical distribution of stem/progenitor and 
differentiated cells in colonoids formed under standard culture conditions.19 Compared to 
freshly isolated crypts, colonoids lacked clear proliferative and differentiated regions.
In vitro response of colonoids to Wnt-3A and γ-secretase inhibitor LY-411575
To demonstrate the utility of the microstrainer array platform, the arrays of CAG-DsRed/
Sox9-EGFP crypts were exposed to two reagents, Wnt-3A and LY-411575. Wnt signaling is 
a major driving force behind intestinal cell renewal and is essential for in vitro growth of 
crypts into colonoids.17, 35 To confirm the role of Wnt-3A, crypts were cultured on the 
microstrainer arrays and images of DsRed fluorescence intensity were acquired every 30 
min (Fig. 5A, B). In the presence of Wnt-3A, the DsRed fluorescence intensity of crypts 
increased steadily over time up to 68 h, indicating expansion of the crypts into colonoids. In 
the absence of Wnt-3A, however, DsRed fluorescence decreased over the time in culture as 
cell numbers declined. This result demonstrates the critical role of Wnt-3A in culturing 
colonic crypts and the utility of the arrays in tracking the of growth factors at the individual 
colonoid level.
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LY-411575 is a γ-secretase inhibitor known to block Notch signaling.36 Inhibition of Notch 
signaling acts to increase differentiation signals along the secretory lineage and decrease 
stem cell numbers.37, 38 To study the effect of LY-411575 on crypts, crypts were cultured on 
the microstrainer arrays in the presence of 0 and 1 μM LY-411575 (Fig. 5C, D). After 
exposure of LY-411575 for 48 h, the colonoids were fixed and their nuclei were stained with 
Hoechst 33342. The location of each colonoid on the microstrainer array was determined by 
having a user initialize the positions of the array’s corners and interpolating the position of 
each well on the array. Hoechst and EGFP fluorescence were integrated over the area of 
each well after background subtraction. EGFP expression was reduced by 39.4% reduction 
compared to that of the control (P < 0.05, student’s t test) (Fig 5D). The results demonstrate 
that Sox9EGFP expression (Fig. 5C) was suppressed by administration of 1 μM of 
LY-411575 suggesting a decrease in functional stem/progenitor cells. No significant change 
in colonoid DNA content was observed (P = 0.087 >0.05, Fig. 5C) between the control and 
drug-exposed arrays indicating that total cell numbers were similar on both arrays and the 
drug did not act by killing cells. LY-411575 did not inhibit the survival of colonoids on the 
arrays at 48 h. Our data is consistent with a previous report that LY-411575 induces 
differentiation of intestinal stem cells and reduces expression of the stem cell marker Lgr5.21 
While a significant difference in the mean level of EGFP fluorescence was observed, 
tracking individual colonoids revealed significant heterogeneity within each population.
Conclusions
An integrated platform possessing microfluidic channels and a microstrainer array was 
fabricated and used to capture and culture colonic crypts that developed into colonoids. 
Captured colonic crypts or organoids were retained on the microstrainer array with >90% 
filling efficiency. A simple operation (filling and then aspiration) generated micron-scale 
Matrigel pockets that encapsulated the crypts and colonoids within the microwells on the 
array. The crypts and colonoids grew within the microstrainers to form or maintain viable 
3D colonoids that possessed the entire cell lineages found in intact crypts. Large numbers of 
colonoids were rapidly screened on the microstrainer arrays without a need for 
computationally expensive image segmentation as the position of each microstrainer within 
the array was predefined. By combining the arrays with wide-field imaging, >400 colonoids 
could be captured per image frame. The arrays enabled rapid in vitro analysis of primary 
colonic tissues during drug exposure and may find usage as a screening tool to identify 
potential adverse gastrointestinal effects of orally administered drugs. This study 
demonstrated for the first time that extremely fragile specimens, such as crypts, can be 
captured and cultured in a microengineered device to form viable structures.
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Refer to Web version on PubMed Central for supplementary material.
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Development of colonoids derived from intact crypts. (A) Simplified model of cell 
composition and tissue polarization for crypts (upper structure) and colonoids (lower 
structure). Stem/progenitor cells are depicted in green, and differentiated cells are red. (B) 
Microscopic images of in vitro growth of crypts over 3 days. The left panel shows a large 
number of crypts/colonoids in low magnification brightfield images. The middle panel 
shows 2–3 crypts/colonoids in high magnification brightfield images. The right panel shows 
the merged red/green fluorescence images of crypts/colonoids isolated from the murine 
model system expressing EGFP and DsRed.
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The microstrainer array and integrated fluidic device. (A) A scheme to fabricate the PDMS 
microstrainer array by replicate molding under pressure. (B–C) Microscopic images of the 
array: (B) brightfield and (C) SEM. Scale bar = 200 μm. (D) The integrated platform was 
composed of two microfluidic layers and one array. They were in order: a PDMS top piece 
(green), a PDMS microstrainer array (purple), and a PDMS bottom piece (green). (E) Top 
view of the assembled device. The numbers label the different access ports between the 
reservoirs and the compartments. (F) A photograph of the device with an exterior dimension 
of 30 × 30 × 10 mm.
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Capture of crypts/colonoids on the microstrainer array and selective placement of Matrigel. 
(A) Cross-sectional view of the device as the compartment contents were sequentially 
loaded. i) Device. ii) Capture of crypts. iii) Placement of liquid Matrigel. iv) Aspiration of 
liquid Matrigel from luminal and basal compartments and solidification of the Matrigel 
remaining within the microstrainer wells. v) Addition of medium to the luminal and basal 
compartments. (B–E) Capture of crypts/colonoids on the array. (B) Brightfield image of 64 
capture sites filled with crypts. (C) Red fluorescence image of B. (D) A single crypt is 
shown captured in a microstrainer. (E) A single colonoid is captured in a microstrainer. (F) 
Confocal fluorescence image of Matrigel pockets formed in the microstrainer array. (G–H) 
Shown are nonconfocal fluorescence (G) and confocal fluorescence (H) images of a crypt 
encapsulated within a Matrigel pocket in the microstrainer. The panels display the merged 
red/green fluorescence images. The Matrigel was mixed with 100 μg/mL fluorescein-dextran 
in images F through G.
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Culture of crypts/colonoids in PDMS microstrainers. A crypt (A) or colonoid (B) was 
loaded into a microstrainer on the array. By 72 h, a colonoid formed filling the 
microstrainer. The top panels are brightfield images of the same microstrainer site while the 
lower panels are overlaid red/green fluorescence images of the array site. (C) Widefield 
images (7 × 7 mm) of the tissue array composed of viable, 3D colonoids. The array 
possessed 900 microstrainers. The upper panel is a brightfield image, and the lower panel is 
an overlaid red/green fluorescence image. (D) Immunofluorescence staining. Cell 
composition in freshly isolated crypts (left panel) and colonoids formed in the microstrainers 
(right panel). Immunofluorescence images are shown for samples stained for: (i) Sox9 
(green, stem/progenitor cells), (ii) Muc2 (red, goblet cells), (iii) chromogranin A (red, 
enteroendocrine cells), and (iv) carbonic anhydrase II (red, enterocytes). Hoechst 33342 was 
used as a counter stain to mark the nuclei (blue) in all images. The lumen of crypts faces 
upward. White dashed circles in the bottom panel indicate the perimeter of the microstrainer 
well.
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Response of colonoids to Wnt-3A (A, B) and γ-secretase inhibitor LY-411575 (C, D). (A) 
DsRed fluorescence intensity normalized to the first time-point vs. time for 55 colonoids in 
the presence of Wnt-3A, and 47 colonoids in the absence of Wnt-3A. (B) Average 
fluorescence intensity vs. time for the colonoids. (C) Scatter plot showing EGFP and 
Hoechst 33342 fluorescence levels of individual colonoids after a 48-h exposure to 1 μM 
(blue) and 0 μM (red) LY-411575. (D) Fluorescence intensity of colonoids. Student’s t test: 
* (P < 0.05), NS (not significant, P > 0.05). The whiskers in the plot show, respectively, the 
upper and lower inner fence value, defined as the 25th percentile minus and 75th percentile 
plus 1.5 times the interquartile range.
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